Graham Capital Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.1M Sell
94,475
-4,146
-4% -$51.7K 0.03% 411
2025
Q4
$1.13M Buy
98,621
+47,655
+94% +$559K 0.03% 364
2025
Q3
$647K Buy
50,966
+40,141
+371% +$582K 0.01% 524
2025
Q2
$172K Sell
10,825
-207,002
-95% -$3.1M ﹤0.01% 1148
2025
Q1
$3.25M Buy
+217,827
New +$3.86M 0.06% 197
2024
Q3
Sell
-19,783
Closed -$493K 1379
2024
Q2
$493K Sell
19,783
-101,306
-84% -$2.91M 0.01% 592
2024
Q1
$4.02M Buy
+121,089
New +$4.14M 0.08% 144
2023
Q4
Sell
-30,753
Closed -$1.05M 1386
2023
Q3
$1.05M Buy
30,753
+5,366
+21% +$204K 0.02% 350
2023
Q2
$1.02M Buy
+25,387
New +$1.01M 0.03% 362

Other funds holding XRAY

Graham Capital Management's XRAY Position: Q1 2026 in Review

Graham Capital Management reduced its Dentsply Sirona (XRAY) stake by 4.2% in Q1 2026, selling an estimated $51.7K and leaving 94,475 shares worth $1.1M. The position accounts for 0.03% of the portfolio, ranked #411.

Graham Capital Management first reported a position in XRAY in Q2 2023 and has held it in 9 quarters since. The position peaked at $4.02M in Q1 2024. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Graham Capital Management held 94,475 shares of Dentsply Sirona worth $1.1M as of Q1 2026.
  • Graham Capital Management sold 4,146 Dentsply Sirona shares in Q1 2026, an estimated $51.7K.
  • Dentsply Sirona made up 0.03% of Graham Capital Management's portfolio in Q1 2026, its #411 holding.
  • Graham Capital Management first reported a position in Dentsply Sirona in Q2 2023 and has held it in 9 quarters since.
  • Graham Capital Management's Dentsply Sirona position peaked at $4.02M in Q1 2024.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.